Work of the WIN consortium and challenges of personalised cancer therapy

Tumour-infiltrating immune cells as classifiers and predictors of outcome

Growing tissue stem cells into organoids and tumeroids: Predictive assay development

Cancer stem cells and malignant progression

microRNA replacement in malignant pleural mesothelioma

IDH1 mutation in haemato-oncology

EORTC fosters move towards tailored cancer treatment through the SPECTA initiative in colorectal cancer

Philadelphia chromosome and the role it plays in chronic myeloid leukaemia

Novel targeting in acute myeloid leukaemia

Treatment of acute lymphoblastic leukaemia by activation of patient's immune cells by a bispecific antibody

Better understandings of gene mutations aid diagnostic tools in CLL

Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL